VA Awards $2.4M Bridge Contract for Roche Histology Services Amidst Ongoing Competition Concerns
Contract Overview
Contract Amount: $239,858 ($239.9K)
Contractor: Roche Diagnostics Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2026-04-02
End Date: 2027-04-01
Contract Duration: 364 days
Daily Burn Rate: $659/day
Competition Type: NOT COMPETED
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: EMERGENCY HISTOLOGY ROCHE ONE YEAR BRIDGE
Place of Performance
Location: INDIANAPOLIS, MARION County, INDIANA, 46256
State: Indiana Government Spending
Plain-Language Summary
Department of Veterans Affairs obligated $239,857.65 to ROCHE DIAGNOSTICS CORPORATION for work described as: EMERGENCY HISTOLOGY ROCHE ONE YEAR BRIDGE Key points: 1. The VA is extending a contract for histology services with Roche Diagnostics, totaling $2.4 million. 2. The contract was not competed, raising questions about market competition and potential price discovery. 3. This bridge contract suggests a potential gap in services or a delay in a more competitive procurement. 4. The sector involves analytical laboratory instruments, a critical area for healthcare diagnostics.
Value Assessment
Rating: questionable
The contract value of $2.4 million for a one-year bridge is significant. Without competitive bidding, it's difficult to assess if this price is optimal compared to market alternatives for similar histology services and equipment.
Cost Per Unit: N/A
Competition Analysis
Competition Level: sole-source
The contract was 'NOT COMPETED,' indicating a sole-source award to Roche Diagnostics. This limits price discovery and may prevent other qualified vendors from offering their services, potentially leading to higher costs.
Taxpayer Impact: Taxpayers may be paying a premium due to the lack of competition, as the government did not explore potentially lower-cost options from other providers.
Public Impact
Veterans may experience continuity of essential histology services, crucial for accurate medical diagnoses. The lack of competition could impact the VA's ability to secure the best value for taxpayer dollars in the long term. This award highlights potential challenges in the VA's procurement process for specialized medical equipment and services.
Waste & Efficiency Indicators
Waste Risk Score: 65 / 10
Warning Flags
- Lack of competition
- Potential for overpayment
- Reliance on a single vendor
Positive Signals
- Ensures continuity of critical services
- Bridge contract allows time for a more robust procurement
Sector Analysis
The analytical laboratory instrument manufacturing sector is vital for healthcare diagnostics. Spending in this area is typically driven by technological advancements and the need for accurate testing. Benchmarks are hard to establish without knowing the specific services and equipment covered.
Small Business Impact
This contract does not appear to involve small businesses, as it was awarded directly to a large corporation, Roche Diagnostics. There is no indication of subcontracting opportunities for small businesses in this specific award.
Oversight & Accountability
The 'NOT COMPETED' status warrants further oversight to ensure the VA is actively pursuing competitive strategies for future procurements to achieve better value and manage costs effectively.
Related Government Programs
- Analytical Laboratory Instrument Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Lack of competitive bidding
- Potential for inflated pricing
- Limited vendor options
- Extended reliance on a single supplier
- Oversight needed on future procurement strategy
Tags
analytical-laboratory-instrument-manufac, department-of-veterans-affairs, in, purchase-order, 100k-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $239,857.65 to ROCHE DIAGNOSTICS CORPORATION. EMERGENCY HISTOLOGY ROCHE ONE YEAR BRIDGE
Who is the contractor on this award?
The obligated recipient is ROCHE DIAGNOSTICS CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $239,857.65.
What is the period of performance?
Start: 2026-04-02. End: 2027-04-01.
What is the VA's strategy to ensure competitive pricing for histology services beyond this bridge contract?
The VA's strategy should involve a thorough market analysis to identify potential competitors and develop a robust solicitation that encourages broad participation. This includes clearly defining the scope of work and performance requirements to allow vendors to propose innovative and cost-effective solutions, thereby ensuring competitive pricing for future contracts.
What are the risks associated with relying on a sole-source provider for critical medical equipment and services?
Sole-source reliance carries risks such as inflated prices due to lack of competition, potential vendor lock-in limiting flexibility, and reduced innovation as the vendor may face less pressure to improve offerings. It also increases vulnerability if the sole provider experiences disruptions, potentially impacting essential services.
How does this contract contribute to the VA's overall mission effectiveness in providing healthcare to veterans?
This bridge contract ensures the immediate continuity of essential histology services, which are critical for accurate diagnosis and treatment planning for veterans. While it addresses an immediate need, the lack of competition raises concerns about long-term cost-effectiveness and the VA's ability to leverage market dynamics for optimal value, potentially impacting overall mission efficiency.
Industry Classification
NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing
Product/Service Code: MEDICAL SERVICES › LABORATORY TESTING SERVICES
Competition & Pricing
Extent Competed: NOT COMPETED
Solicitation Procedures: ONLY ONE SOURCE
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Roche Holding AG
Address: 9115 HAGUE RD, INDIANAPOLIS, IN, 46256
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $239,858
Exercised Options: $239,858
Current Obligation: $239,858
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Timeline
Start Date: 2026-04-02
Current End Date: 2027-04-01
Potential End Date: 2027-04-01 00:00:00
Last Modified: 2026-04-01
More Contracts from Roche Diagnostics Corporation
- THE Purpose of This Contract IS to Procure the Procurement of Over the Counter (OTC) Covid-19 Tests — $90.6M (Department of Health and Human Services)
- Cost PER Test — $13.5M (Department of Veterans Affairs)
- CPT — $5.5M (Department of Veterans Affairs)
- Chemistry-Immunochemistry CPR — $4.6M (Department of Veterans Affairs)
- FY22 CPT Chemistry Analyzer — $4.2M (Department of Health and Human Services)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)